Dr. Lahdan Refahiyat, MD

Dr. Refahiyat practices at Carson Tahoe Advanced Neurosurgery - HOPD in Carson City, Nevada.

Dr. Refahiyat's NPI, 1801246731, was assigned on June 22, 2016. Dr. Refahiyat graduated from Michigan State University College of Human Medicine in 2016. Dr. Refahiyat holds Nevada license 24089.

Dr. Refahiyat's primary practice is Carson Tahoe Advanced Neurosurgery - HOPD, at 1470 Medical Pkwy, Carson City, NV 89703.

Dr. Refahiyat's primary practice is Carson Tahoe Advanced Neurosurgery - HOPD in Carson City, Nevada. Dr. Refahiyat is also affiliated with Carson Tahoe Regional Medical Center. The medical group on file is Carson Tahoe Medical Group. Dmand AI also links Dr. Refahiyat to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Refahiyat practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Refahiyat's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Refahiyat is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Refahiyat's licenses on file in 2 states: Nevada and Michigan.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, heart blockage, heart failure and heart valve disorders among the conditions Dr. Refahiyat treats.

CMS data shows 1,468 Medicare services from Dr. Refahiyat across 19 procedure codes in 2024, for 672 Medicare patients. Medicare paid $92,950 for them.

CMS counts 672 Medicare patients who saw Dr. Refahiyat in 2024. The largest group is 65 to 74, with 279 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Refahiyat's median patient age at 71, with 51% women.

In 2024, Dr. Refahiyat wrote 1,857 Medicare Part D claims for 349 patients. 84% of them were for generic drugs. CMS names the drug for 1,712 of them, across 27 drugs with 11 or more claims each, at $244,145 in total drug cost. In 2023, CMS named 103 claims across 6 drugs.

Dr. Refahiyat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 35 procedures of coronary angioplasty and stenting by Dr. Refahiyat, more than 72% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Refahiyat, published from 2018 to 2023. The most frequent topics are Coronary Angiography, Occupational Exposure and Radiation Dosage. Dr. Refahiyat has published most often in Cardiovasc Revasc Med. Dr. Refahiyat's most frequent co-authors are Ryan D. Madder, MD, Gail M. Annich, MD and Timothy Andrew Joseph, MD.

CMS Open Payments shows 158 general payments to Dr. Refahiyat from 18 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 52% of the total. Medtronic, Inc. paid the most, $4,258.

Dr. Refahiyat graduated from Michigan State University College of Human Medicine in 2016.

Dr. Refahiyat is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.